Formula & Concentration

CIMZIA (certolizumab pegol) Lyophilized powder or solution for subcutaneous use

Manufacturer

UCB

Indications

CIMZIA is a tumor necrosis factor (TNF) blocker indicated for:

  • Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
  • Treatment of adults with moderately to severely active rheumatoid arthritis

Product Options

Package Size

NDC #

Presentation

Lyophilized powder for reconstitution kit

50474-0700-62

2 x 200 mg vials

Prefilled syringe kit

50474-0710-79

2 X 200 mg/mL prefilled syringes

Prefilled syringe starter kit

50474-0710-81

6 X 200 mg/mL prefilled syringes

Shelf Life and Storage

  • Refrigerate intact carton at 2° to 8° C (36° to 46° F). Do not freeze. Do not separate contents of carton prior to use. Do not use beyond expiration date, which is located on the drug label and carton.
  • Protect solution from light.